72 related articles for article (PubMed ID: 30967332)
1. The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy.
Takamatsu K; Matsumoto K; Shojo K; Tanaka N; Takeda T; Morita S; Kosaka T; Mizuno R; Shinojima T; Kikuchi E; Asanuma H; Oya M
Urol Oncol; 2019 Sep; 37(9):575.e19-575.e25. PubMed ID: 30967332
[TBL] [Abstract][Full Text] [Related]
2. Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized Cohort.
Fine SW; Al-Ahmadie HA; Vertosick E; Vickers AJ; Chen YB; Gopalan A; Sarungbam J; Sirintrapun SJ; Tickoo SK; Eastham JA; Scardino PT; Reuter VE
Urol Pract; 2022 Sep; 9(5):459-465. PubMed ID: 37145713
[TBL] [Abstract][Full Text] [Related]
3. Short-term prognosis of low-risk prostate cancer patients is favorable despite the presence of pathological prognostic factors: a retrospective study.
Semba R; Uchida K; Hirokawa Y; Shiraishi T; Onishi T; Sasaki T; Inoue T; Watanabe M
BMC Urol; 2023 Oct; 23(1):174. PubMed ID: 37904171
[TBL] [Abstract][Full Text] [Related]
4. Prostate Cancer Risk Stratification by Simple Scoring of the Current pT3 Lesions: A Proposal for a New Pathologic T-Staging System.
Miyamoto H; Teramoto Y; Numbere N; Wang Y; Joseph JV
Mod Pathol; 2024 Mar; 37(3):100429. PubMed ID: 38266919
[TBL] [Abstract][Full Text] [Related]
5. The association of body mass index with tumor aggression among men undergoing radical prostatectomy.
Gregg JR; Magill R; Fang AM; Chapin BF; Davis JW; Adibi M; Chéry L; Papadopoulos J; Pettaway C; Pisters L; Ward JF; Hahn AW; Daniel CR; Bhaskaran J; Zhu K; Guerrero M; Zhang M; Troncoso P
Urol Oncol; 2024 Apr; 42(4):116.e1-116.e7. PubMed ID: 38262868
[TBL] [Abstract][Full Text] [Related]
6. Do prostatic transition zone tumors have a distinct morphology?
Garcia JJ; Al-Ahmadie HA; Gopalan A; Tickoo SK; Scardino PT; Reuter VE; Fine SW
Am J Surg Pathol; 2008 Nov; 32(11):1709-14. PubMed ID: 18769336
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of zonal origin in clinically localized prostate cancer: a systematic review and meta-analysis.
Jin S; Wu L; Liang Z; Yan W
Front Oncol; 2023; 13():1248222. PubMed ID: 38144521
[TBL] [Abstract][Full Text] [Related]
8. Head-to-Head Comparison of
Kuten J; Fahoum I; Savin Z; Shamni O; Gitstein G; Hershkovitz D; Mabjeesh NJ; Yossepowitch O; Mishani E; Even-Sapir E
J Nucl Med; 2020 Apr; 61(4):527-532. PubMed ID: 31562225
[No Abstract] [Full Text] [Related]
9. Seminal vesicle invasion combined with extraprostatic extension is associated with higher frequency of biochemical recurrence and lymph node metastasis than seminal vesicle invasion alone: Proposal for further pT3 prostate cancer subclassification.
Rehman A; El-Zaatari ZM; Han SH; Shen SS; Ayala AG; Miles B; Divatia MK; Ketcham MS; Chung BM; Rogers JT; Ro JY
Ann Diagn Pathol; 2020 Dec; 49():151611. PubMed ID: 32956915
[TBL] [Abstract][Full Text] [Related]
10. Single-cell transcriptome analysis reveals liver injury induced by glyphosate in mice.
Wu J; Sun X; Wu C; Hong X; Xie L; Shi Z; Zhao L; Du Q; Xiao W; Sun J; Wang J
Cell Mol Biol Lett; 2023 Feb; 28(1):11. PubMed ID: 36739397
[TBL] [Abstract][Full Text] [Related]
11. Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer.
Kallenbach J; Atri Roozbahani G; Heidari Horestani M; Baniahmad A
Cell Biosci; 2022 Dec; 12(1):200. PubMed ID: 36522745
[TBL] [Abstract][Full Text] [Related]
12. Spatially resolved clonal copy number alterations in benign and malignant tissue.
Erickson A; He M; Berglund E; Marklund M; Mirzazadeh R; Schultz N; Kvastad L; Andersson A; Bergenstråhle L; Bergenstråhle J; Larsson L; Alonso Galicia L; Shamikh A; Basmaci E; Díaz De Ståhl T; Rajakumar T; Doultsinos D; Thrane K; Ji AL; Khavari PA; Tarish F; Tanoglidi A; Maaskola J; Colling R; Mirtti T; Hamdy FC; Woodcock DJ; Helleday T; Mills IG; Lamb AD; Lundeberg J
Nature; 2022 Aug; 608(7922):360-367. PubMed ID: 35948708
[TBL] [Abstract][Full Text] [Related]
13. Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils the Characteristics of the Immune Microenvironment and Prognosis Signature in Prostate Cancer.
Wang R; Xiao Y; Pan M; Chen Z; Yang P
J Oncol; 2022; 2022():6768139. PubMed ID: 35909899
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts in the single-cell era.
Lavie D; Ben-Shmuel A; Erez N; Scherz-Shouval R
Nat Cancer; 2022 Jul; 3(7):793-807. PubMed ID: 35883004
[TBL] [Abstract][Full Text] [Related]
15. Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes.
Trigos AS; Pasam A; Banks P; Wallace R; Guo C; Keam S; Thorne H; ; Mitchell C; Lade S; Clouston D; Hakansson A; Liu Y; Blyth B; Murphy D; Lawrentschuk N; Bolton D; Moon D; Darcy P; Haupt Y; Williams SG; Castro E; Olmos D; Goode D; Neeson P; Sandhu S
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764368
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive assessment of cellular senescence in the tumor microenvironment.
Wang X; Ma L; Pei X; Wang H; Tang X; Pei JF; Ding YN; Qu S; Wei ZY; Wang HY; Wang X; Wei GH; Liu DP; Chen HZ
Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35419596
[TBL] [Abstract][Full Text] [Related]
17. Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment.
Tong D
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383112
[TBL] [Abstract][Full Text] [Related]
18. Single-Cell RNA-seq Reveals a Developmental Hierarchy Super-Imposed Over Subclonal Evolution in the Cellular Ecosystem of Prostate Cancer.
Ge G; Han Y; Zhang J; Li X; Liu X; Gong Y; Lei Z; Wang J; Zhu W; Xu Y; Peng Y; Deng J; Zhang B; Li X; Zhou L; He H; Ci W
Adv Sci (Weinh); 2022 May; 9(15):e2105530. PubMed ID: 35322584
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer.
Kang J; La Manna F; Bonollo F; Sampson N; Alberts IL; Mingels C; Afshar-Oromieh A; Thalmann GN; Karkampouna S
Cancer Lett; 2022 Apr; 530():156-169. PubMed ID: 35051532
[TBL] [Abstract][Full Text] [Related]
20. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states.
Song H; Weinstein HNW; Allegakoen P; Wadsworth MH; Xie J; Yang H; Castro EA; Lu KL; Stohr BA; Feng FY; Carroll PR; Wang B; Cooperberg MR; Shalek AK; Huang FW
Nat Commun; 2022 Jan; 13(1):141. PubMed ID: 35013146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
